Skip to main content

Scheme Description

A total of three clinical scenarios will be distributed throughout the year, covering haematopoietic stem cell transplantation, solid organ transplantation and platelet/transfusion immunology.

Laboratories can register to receive some or all of the scenarios. The educational clinical scenarios will be distributed to participants by e-mail and are provided free of charge to participants of other UK NEQAS for H&I Schemes.

Participants are encouraged to discuss the scenarios in laboratory meetings or distribute to relevant staff to get the maximum benefit to the laboratory. Even if the laboratory does not undertake the particular test mentioned in the scenario or offer the service (e.g. platelet support or cord blood transplantation), participants are encouraged to respond based on H&I knowledge, published evidence and relevant guidelines (where applicable).

 

Purpose

To provide participants with a variety of interesting samples to test that offer a beneficial educational element.

Laboratories can register to receive the interpretive clinical scenarios free of charge if they are currently registered with any other UK NEQAS for H&I EQA/EPT scheme.

 

Samples

One clinical scenario will be provided, three times a year. The scenarios are emailed to participants as well as being made available on the participant portal.

The scenarios will cover various topics within the H&I field including HSCT, solid organ transplantation and platelet/transfusion immunology.

 

Reporting

Participants must only use the reporting forms provided on the participant’s portal and are required to report their findings within the deadline stated.

 

Assessment

The scheme iED scenarios are not assessed.

 

 

Satisfactory Performance

Not applicable.

                                                                                                                  

Information/Analysis Provided to Participants

  • For scenarios, an anonymised summary of all returns and an analysis of responses will be issued after each distribution